Heavy-light chain mispairing is one of the major concerns for producing bispecific antibodies. bYlok™ technology is a design engineering approach that solves this whist retaining molecule's closer-to-nature structure and simplified downstream purification.
You may also be interested in:
Out-Licensed Expression Technologies
Bispecific Antibody
Cell Line Development
Mammalian Expression Technologies
GS Gene Expression System®
GS Xceed® Gene Expression System
GS piggyBac® Transposon System
bYlok™ Bispecific Antibodies Technology
GSquad® Vectors
Author(s):
Lisa Prendergast, Ph.D.
Associate Director, Expression System Sciences
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center
Center of Applied Sustainability
Article
Lonza CHI’s Center of Applied Sustainability
Sustainability is at the core of our business strategy and operating philosophy. At Lonza CHI, we...
Lonza_Bend_InhalationLab.010
White paper
The Role of Excipients in Inhaled Biologics
The field of inhaled biologics is rapidly expanding, with both dry and liquid formulations of...
CDMO Notes Blog post
Accelerated Tox Offerings: A Recipe for Streamlining IND Applications
Webinar (on-demand)
Lonza Biologics Drug Product OPCU Capacity Update
Explore Lonza Biologics' end-to-end Drug Product capabilities along the full life cycle, seamlessly...
Capsule services
Brochure
Technical Services Portfolio Brochure
For over 50 years, we have built a comprehensive portfolio of technical services, providing our...
Lonza Bend Solid Form Services
Webinar (on-demand)
De-Risking Early Phase Micronization with Integrated Solid Form Selection
Achieving the right particle size for respiratory drug delivery is crucial, and jet milling is a...
Thumbnail of page regulatory-compliance-redno3-colorant
Article
Embrace Regulatory Changes with Lonza
On January 15, 2025, the U.S. FDA announced that FD&C Red No. 3 (erythrosine, E127) colorant will no...
Microdosing graphic
Article
Accelerating Drug Development with Precision Powder Micro-Dosing
Webinar (on-demand)
Producing Engineered Extracellular Vesicles with a Platform Approach
In this webinar, we'll discuss materials and methods to enable the expression of biomolecules on...
Visp HPAPI Kg Suite
R&D Blog post
Delivering a consistently excellent service with advanced process technologies
As a chemical engineer, it’s perhaps unsurprising that I find it immensely satisfying to use...
TiO2 capsules thumbnail image for KC
Brochure
Lonza Has You Covered: The Ultimate Titanium Dioxide-free Offering
Explore Lonza’s cutting-edge Titanium Dioxide-free products and services. As regulatory...
CDMO Notes Blog post
A Faster Path to the Clinic: Accelerating Biologics Development with Integrated Solutions
How Lonza’s team are helping to revolutionise the path to Biologics INDs, with an accelerated...